8-K

Cryoport, Inc. (CYRX)

8-K 2022-05-05 For: 2022-04-29
View Original
Added on April 06, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 29, 2022


CRYOPORT, INC.

(Exact name of registrant as specified in its charter)

Nevada 001-34632 88-0313393
(State or other jurisdiction<br><br>of incorporation) (Commission File Number) (IRS Employer<br><br>Identification No.)
112 Westwood Place**, Suite 350** Brentwood , TN 37027
(Address of principal executive offices, including zip code)
Registrant’s telephone number, including area code: (949) 470-2300
Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
--- ---
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
--- ---
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
--- ---

Securities registered pursuant to Section12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.001 par value CYRX The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 5.07 Submission of Matters to a Vote of Security Holders.

On April 29, 2022, Cryoport, Inc. (the “Company”) held its 2022 Annual Meeting of Stockholders (the “Annual Meeting”). The final voting results for the proposals submitted to a vote of stockholders at the Annual Meeting, each of which is described in detail in the Company’s proxy statement filed with the U.S. Securities and Exchange Commission on March 18, 2022 (the “Proxy Statement”), are set forth below.

Proposal No. 1: Election of Directors. The individuals listed below were elected to serve as directors of the Company until the Company’s 2023 Annual Meeting of Stockholders or until their successors are duly elected and qualified or their earlier death, resignation, or removal:

Director Nominee Votes For Votes Withheld Broker Non-Votes
Linda Baddour 43,773,463 831,731 3,445,711
Richard Berman 33,434,694 11,170,500 3,445,711
Daniel M. Hancock 43,881,898 723,296 3,445,711
Robert Hariri, M.D., Ph.D. 31,954,211 12,650,983 3,445,711
Ram M. Jagannath 43,635,077 970,117 3,445,711
Ramkumar Mandalam, Ph.D. 31,536,273 13,068,921 3,445,711
Jerrell W. Shelton 43,391,103 1,214,091 3,445,711
Edward J. Zecchini 43,854,503 750,691 3,445,711

Proposal No. 2: Ratification of the appointmentof Ernst & Young LLP as the independent registered public accounting firm of the Company and its subsidiaries for the year endingDecember 31, 2022. This proposal was approved as set forth below:

Votes For Votes Against Abstentions Broker Non-Votes
48,042,299 6,749 1,857

Proposal No. 3: Advisory vote to approve thecompensation of the Company’s named executive officers, as disclosed in the Proxy Statement. This proposal was approved as set forth below:

Votes For Votes Against Abstentions Broker Non-Votes
43,353,996 1,237,797 13,401 3,445,711

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: May 5, 2022 Cryoport Inc.
/s/ Robert Stefanovich
Robert Stefanovich
Chief Financial Officer